Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Sutherland

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Blood|March 1, 1994
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapyD E Reece, J M Connors, J J Spinelli, et al.
Blood Cells|January 1, 1992
The human hematopoietic stem cell in vitro and in vivoC J Eaves, H J Sutherland, C Udomsakdi, et al.
British Journal of Cancer|September 1, 1993
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumoursM J Barnett, C M Coppin, N Murray, et al.
Bone Marrow Transplantation|September 1, 1994
Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administrationH G Klingemann, C J Eaves, M J Barnett, et al.
Leukemia|November 1, 1992
Autografting in chronic myeloid leukemia with cultured marrowM J Barnett, C J Eaves, G L Phillips, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver StudyM J Barnett, C J Eaves, G L Phillips, et al.
Bone Marrow Transplantation|December 1, 1993
Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphomaJ D Shepherd, M J Barnett, J M Connors, et al.
Blood|July 15, 1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapyD E Reece, M J Barnett, J D Shepherd, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1995
Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experienceR J Cuthbert, J D Shepherd, S H Nantel, et al.
Bone Marrow Transplantation|January 1, 1991
Human hematopoietic stem cells in long-term culture: quantitation and manipulationM J Barnett, H J Sutherland, A C Eaves, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Blood|March 1, 1994
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapyD E Reece, J M Connors, J J Spinelli, et al.
Blood Cells|January 1, 1992
The human hematopoietic stem cell in vitro and in vivoC J Eaves, H J Sutherland, C Udomsakdi, et al.
British Journal of Cancer|September 1, 1993
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumoursM J Barnett, C M Coppin, N Murray, et al.
Bone Marrow Transplantation|September 1, 1994
Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administrationH G Klingemann, C J Eaves, M J Barnett, et al.
Leukemia|November 1, 1992
Autografting in chronic myeloid leukemia with cultured marrowM J Barnett, C J Eaves, G L Phillips, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver StudyM J Barnett, C J Eaves, G L Phillips, et al.
Bone Marrow Transplantation|December 1, 1993
Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphomaJ D Shepherd, M J Barnett, J M Connors, et al.
Blood|July 15, 1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapyD E Reece, M J Barnett, J D Shepherd, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1995
Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experienceR J Cuthbert, J D Shepherd, S H Nantel, et al.
Bone Marrow Transplantation|January 1, 1991
Human hematopoietic stem cells in long-term culture: quantitation and manipulationM J Barnett, H J Sutherland, A C Eaves, et al.
Pageof 11